Eck Stephen L. 4
4 · MACROGENICS INC · Filed Feb 11, 2025
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Eck Stephen L.
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-02-08$2.60/sh−3,312$8,611→ 17,654 total - Award
Restricted Stock Unit
2025-02-07+19,000→ 19,000 total→ Common Stock (19,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-08−11,168→ 22,332 totalExercise: $0.00→ Common Stock (11,168 underlying) - Exercise/Conversion
Common Stock
2025-02-08+11,168→ 20,966 total - Award
Employee Stock Option (right to buy)
2025-02-07+113,000→ 113,000 totalExercise: $2.60Exp: 2035-02-07→ Common Stock (113,000 underlying)
Footnotes (3)
- [F1]On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
- [F2]12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
- [F3]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.